Expansion from research on lens hardening into the presbyopia and anti-aging fields
First written in FY2022. 2 of 3 entries say "Advanced", first in FY2023. Latest entry: FY2024.
No other company in this theme has enough history to compare yet.
- FY2024AdvancedAnnual report
「Keio University (Department of Orthopaedic Surgery, School of Medicine) Joint research agreement From 1 April 2024 to 31 March 2025 Analysis of the mechanism of aging control through external light stimulation」
It reports a joint research agreement on the mechanism of aging control through external light stimulation, as part of the expansion from lens-hardening research into aging control and anti-aging. - FY2023AdvancedAnnual report
「In a joint study with the Department of Biochemistry, Keio University School of Medicine, comprehensive analysis of lens metabolism revealed that aging causes not only the lens but also the liver, heart, brain, muscles and other parts of the body to harden.」
New findings have been reported that expand lens-hardening research into systemic aging and anti-aging research. - FY2022First statedAnnual report
「The drug identified through the redevelopment of existing drugs is expected to serve as an anti-aging drug because it not only suppresses hardening of the lens but also suppresses hardening throughout the body.」
The company is expanding into systemic aging control through a lens-hardening measurement device, supplements and the redevelopment of existing drugs.